Triple oral lipid lowering treatment for acute coronary syndrome

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 27 Feb 2026: Trial registered, NCT07440381

The trials

NCT07440381: triPle Oral thERapy With Bempedoic Acid vs uSual Care in Early Lipid Management of Patients With acUte coronAry synDromE

State
Not started
Phase
Phase 3
People
600 planned
Started
Sep 2026
Primary completion
Aug 2027
Arms
High intensity statin plus ezetimibe plus bempedoic acid
Results
None posted
  1. 27 Feb 2026: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.